Pharmaceutical Industry

""The $800 Million Pill is a masterful work of explanatory and investigative journalism. Merrill Goozner has versed himself in the interlocking worlds of medicine, business, politics, and basic science to explain how pharmaceutical breakthroughs truly occur. He also explains why drug costs are now so needlessly high.JThis is a compelling and important book."--James Fallows of The Atlantic Monthly, author of "Breaking the News

"Merrill Goozner does a superb job at explaining just how the pharmaceutical industry gets away with systematic overcharging, and why bio-medical advances do not require the current profiteering. This is the definitive book on this vital topic."--Robert Kuttner, Co-Editor of "The American Prospect and author of "Everything for Sale

"Why do your prescription drugs cost so much? The real answers may surprise you. In a lively and straightforward narrative, veteran journalist Merrill Goozner goes behind the headlines and pharmaceutical industry spin to uncover the politics and the practices that drive up drug costs. His diagnosis and prescriptions make a valuable contribution to the growing national debate over safe, quality and affordable health care for all Americans."--Clarence Page, syndicated columnist for the Chicago Tribune

"Merrill Goozner has written an important book. The high-stakes national debate over what to do about prescription drug coverage and costs too often suffers from a dearth of facts and analysis. This volume helps to fill that gap by illuminating the seemingly opaque world of pharmaceutical research and development."--Susan Dentzer, Health Correspondent for "The News Hour with Jim Lehrer on PBS

This comparative study looks at the early development of biotechnology in the US and Japan.

This third edition of the acclaimed Patents for Chemists provides vital updating and much expanded coverage while retaining the focus upon the relevant technology and industry practices. The book guides the reader through the legal and procedural complexities of the British, European, Japanese and US patent systems, and explains in detail the role of patent practitioners in maximizing the commercial potential of their client's or company's innovative products.